Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxazyme in Patients With Hyperoxaluria
NCT01127087Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2010
- Primary completion
- Sep 2011
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of Oxazyme in hyperoxaluria (2 arms), sponsored by Mayo Clinic. Primary endpoint: Urinary Oxalate Creatinine Ratio at 4 weeks. Started May 2010; status: completed.
02
Drugs
Oxazyme
03
Conditions
hyperoxaluria
Beyond the preview
Go deeper on NCT01127087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127087.